---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-012372"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2026-03-24T23:59:59+00:00"
generated_at: "2026-05-15T09:15:18.596710+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Indaptus Therapeutics change of control: David Lazar sells $11.2M stake; new CEO Junyi Dai appointed

## Summary
- David Lazar sold 700K Series AAA and 196.8K Series AA Preferred shares to five purchasers for $11.2M.
- Purchasers will own 96.2% of diluted shares post-conversion; may be deemed a group under Exchange Act.
- Four directors resigned, including co-CEO Jeffrey Meckler; David Lazar resigned as co-CEO but remains on board.
- Junyi Dai, 39, appointed CEO and Chairman; previously Managing Director at FLMD Pty Ltd and independent director.
- Company to file resale registration statement within 30 days for 2.064M shares underlying Lazar's retained Series AA.

## SEC filing metadata
- accession: 0001493152-26-012372
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2026-03-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.01, 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315226012372/0001493152-26-012372-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315226012372/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-012372
- JSON: https://secwatch.observer/filing/0001493152-26-012372.json
- Plain text: https://secwatch.observer/filing/0001493152-26-012372.txt

## Key facts
- M&A Transactions
  Indaptus Therapeutics, Inc. underwent a change of control involving Yun Yao, Sino Lion Ventures Limited, Junyi Dai, Ting Yang, and Lina Deng for $11,200,000 (closed 2026-03-23).
  - Action: change of control
  - Counterparty: Yun Yao, Sino Lion Ventures Limited, Junyi Dai, Ting Yang, and Lina Deng
  - Consideration: $11,200,000
  - Closing: 2026-03-23
  source text: on March 23, 2026, David Lazar sold, in accordance with the rights afforded to Mr. Lazar in the Purchase Agreement, all of his interest and rights in the 700,000 shares of Series AAA Preferred Stock and all of his interest and rights to 196,800 shares of Series AA Preferred Stock to Yun Yao, Sino Lion Ventures Limited, Junyi Dai, Ting Yang, and Lina Deng (the “Purchasers”) in certain percentages set forth in the definitive agreements related to such transaction, for an aggregate purchase price of $11,200,000 (the “Purchase Price”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315226012372/0001493152-26-012372-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.